Prot# M12-895: A Randomized, Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or

Project: Research project

Project Details

StatusFinished
Effective start/end date10/26/12 → 10/26/18

Funding

  • Abbott Laboratories (Prot# M12-895)